The Institute for Precision Medicine is one of several innovative research approaches the AHA is employing to more aggressively attack heart disease and stroke.
The touching stories of heart disease and stroke survivors illustrate exactly why we fund lifesaving research.
Groundbreaking results for nearly a century; new innovations shape decades to come
How we're using emerging technology,
big data and bold new approaches
to save and improve lives:
And we're making a difference. The research we've funded through the generosity of our donors is helping people survive heart disease and stroke. They're living longer and enjoying a better quality of life, thanks to new treatments, prevention strategies and a deeper understanding of these diseases.
In fact, heart disease deaths have declined so steadily over the decades that we are eagerly awaiting the day when it is no longer the leading cause of death in the U.S. We've already seen the stroke death rate drop - from the No. 3 cause of death in the U.S. to No. 5 over just five years.
Our core research programs have launched or furthered the work of many of this country's brightest CVD and stroke researchers. Building on the strength of those programs, we've added research awards that foster team science and accelerate discovery as we relentlessly search for innovative solutions.
Our Strategically Focused Research Networks bring together researchers from top institutions across the country to collaborate on specific topics, such as women and heart disease or high blood pressure. Our Collaborative Science Awards partner researchers from different disciplines, while our merit awards fund highly promising investigators who have the potential to move a field of science forward with creative approaches.
We know that personalized medicine can improve cardiovascular health of individuals and populations. Our Institute for Precision Cardiovascular Medicine is tapping the power of technology and big data to help people find more targeted, safer and more effective treatments and prevention strategies. Our historic endeavor One Brave Idea is awarding $75 million to a single research team aiming to cure coronary heart disease.
Despite our success, there is work to do. We still lack the funding for hundreds of worthy research projects - any of which could be a lifesaving breakthrough just waiting to cure heart disease and stroke, which remain the leading causes of death globally.
Whether channeling the power of our thousands of scientific volunteers who help ensure we fund the most worthy research or boldly exploring untried new research approaches, the driving force behind our efforts never changes:
Saving and improving lives.